In contrast to adenocarcinoma, PD-L1 expression has not been found to be significantly associated with immunotherapy efficacy in squamous cell carcinoma and small cell lung cancer (SCLC) to date [9]. The gene discussed is CD274; the disease is small cell lung carcinoma.